カテゴリー： Market Monitor Global, 世界, 医療/バイオ

二重特異性抗体医薬品の世界市場見通し2023年-2029年

◆英語タイトル：Bispecific Antibodies Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5719）◆商品コード：MMG23JU5719
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Bispecific Antibodies Drug Market 調査レポートは次の情報を含め、グローバルにおけるの二重特異性抗体医薬品市場規模と予測を収録しています。・世界の二重特異性抗体医薬品市場：売上、2018年-2023年、2024年-2029年
・世界の二重特異性抗体医薬品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の二重特異性抗体医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ブリンサイト」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

二重特異性抗体医薬品のグローバル主要企業は、Amgen、 Immunocore、 Rocheなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、二重特異性抗体医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の二重特異性抗体医薬品市場：タイプ別、2018年-2023年、2024年-2029年
世界の二重特異性抗体医薬品市場：タイプ別市場シェア、2022年
・ブリンサイト、キムトラック、ヘムライブラ

世界の二重特異性抗体医薬品市場：用途別、2018年-2023年、2024年-2029年
世界の二重特異性抗体医薬品市場：用途別市場シェア、2022年
・血液がん、固形がん

世界の二重特異性抗体医薬品市場：地域・国別、2018年-2023年、2024年-2029年
世界の二重特異性抗体医薬品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における二重特異性抗体医薬品のグローバル売上、2018年-2023年
・主要企業における二重特異性抗体医薬品のグローバル売上シェア、2022年
・主要企業における二重特異性抗体医薬品のグローバル販売量、2018年-2023年
・主要企業における二重特異性抗体医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Amgen、 Immunocore、 Roche

*************************************************************

・調査・分析レポートの概要
二重特異性抗体医薬品市場の定義
市場セグメント
世界の二重特異性抗体医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の二重特異性抗体医薬品市場規模
世界の二重特異性抗体医薬品市場規模：2022年 VS 2029年
世界の二重特異性抗体医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの二重特異性抗体医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の二重特異性抗体医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ブリンサイト、キムトラック、ヘムライブラ
二重特異性抗体医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：血液がん、固形がん
二重特異性抗体医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別二重特異性抗体医薬品市場規模 2022年と2029年
地域別二重特異性抗体医薬品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Amgen、 Immunocore、 Roche
...

A Bispecific Antibodies is designed to bind two different targets or epitopes and can thereby exert two different functions. They are currently used to treat infectious, inflammatory, and malignant diseases.
This report aims to provide a comprehensive presentation of the global market for Bispecific Antibodies Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibodies Drug. This report contains market size and forecasts of Bispecific Antibodies Drug in global, including the following market information:
Global Bispecific Antibodies Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Bispecific Antibodies Drug Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Bispecific Antibodies Drug companies in 2022 (%)
The global Bispecific Antibodies Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Blincyto Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Bispecific Antibodies Drug include Amgen, Immunocore and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bispecific Antibodies Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bispecific Antibodies Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Bispecific Antibodies Drug Market Segment Percentages, by Type, 2022 (%)
Blincyto
Kimmtrak
Hemlibra
Global Bispecific Antibodies Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Bispecific Antibodies Drug Market Segment Percentages, by Application, 2022 (%)
Hematological Cancers
Solid Tumors
Global Bispecific Antibodies Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Bispecific Antibodies Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bispecific Antibodies Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Bispecific Antibodies Drug revenues share in global market, 2022 (%)
Key companies Bispecific Antibodies Drug sales in global market, 2018-2023 (Estimated), (Units)
Key companies Bispecific Antibodies Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen
Immunocore
Roche
Outline of Major Chapters:
Chapter 1: Introduces the definition of Bispecific Antibodies Drug, market overview.
Chapter 2: Global Bispecific Antibodies Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Bispecific Antibodies Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Bispecific Antibodies Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Bispecific Antibodies Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Bispecific Antibodies Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Bispecific Antibodies Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Bispecific Antibodies Drug Overall Market Size
2.1 Global Bispecific Antibodies Drug Market Size: 2022 VS 2029
2.2 Global Bispecific Antibodies Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Bispecific Antibodies Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Bispecific Antibodies Drug Players in Global Market
3.2 Top Global Bispecific Antibodies Drug Companies Ranked by Revenue
3.3 Global Bispecific Antibodies Drug Revenue by Companies
3.4 Global Bispecific Antibodies Drug Sales by Companies
3.5 Global Bispecific Antibodies Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Bispecific Antibodies Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Bispecific Antibodies Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Bispecific Antibodies Drug Players in Global Market
3.8.1 List of Global Tier 1 Bispecific Antibodies Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Bispecific Antibodies Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Bispecific Antibodies Drug Market Size Markets, 2022 & 2029
4.1.2 Blincyto
4.1.3 Kimmtrak
4.1.4 Hemlibra
4.2 By Type – Global Bispecific Antibodies Drug Revenue & Forecasts
4.2.1 By Type – Global Bispecific Antibodies Drug Revenue, 2018-2023
4.2.2 By Type – Global Bispecific Antibodies Drug Revenue, 2024-2029
4.2.3 By Type – Global Bispecific Antibodies Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Bispecific Antibodies Drug Sales & Forecasts
4.3.1 By Type – Global Bispecific Antibodies Drug Sales, 2018-2023
4.3.2 By Type – Global Bispecific Antibodies Drug Sales, 2024-2029
4.3.3 By Type – Global Bispecific Antibodies Drug Sales Market Share, 2018-2029
4.4 By Type – Global Bispecific Antibodies Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Bispecific Antibodies Drug Market Size, 2022 & 2029
5.1.2 Hematological Cancers
5.1.3 Solid Tumors
5.2 By Application – Global Bispecific Antibodies Drug Revenue & Forecasts
5.2.1 By Application – Global Bispecific Antibodies Drug Revenue, 2018-2023
5.2.2 By Application – Global Bispecific Antibodies Drug Revenue, 2024-2029
5.2.3 By Application – Global Bispecific Antibodies Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Bispecific Antibodies Drug Sales & Forecasts
5.3.1 By Application – Global Bispecific Antibodies Drug Sales, 2018-2023
5.3.2 By Application – Global Bispecific Antibodies Drug Sales, 2024-2029
5.3.3 By Application – Global Bispecific Antibodies Drug Sales Market Share, 2018-2029
5.4 By Application – Global Bispecific Antibodies Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Bispecific Antibodies Drug Market Size, 2022 & 2029
6.2 By Region – Global Bispecific Antibodies Drug Revenue & Forecasts
6.2.1 By Region – Global Bispecific Antibodies Drug Revenue, 2018-2023
6.2.2 By Region – Global Bispecific Antibodies Drug Revenue, 2024-2029
6.2.3 By Region – Global Bispecific Antibodies Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Bispecific Antibodies Drug Sales & Forecasts
6.3.1 By Region – Global Bispecific Antibodies Drug Sales, 2018-2023
6.3.2 By Region – Global Bispecific Antibodies Drug Sales, 2024-2029
6.3.3 By Region – Global Bispecific Antibodies Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Bispecific Antibodies Drug Revenue, 2018-2029
6.4.2 By Country – North America Bispecific Antibodies Drug Sales, 2018-2029
6.4.3 US Bispecific Antibodies Drug Market Size, 2018-2029
6.4.4 Canada Bispecific Antibodies Drug Market Size, 2018-2029
6.4.5 Mexico Bispecific Antibodies Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Bispecific Antibodies Drug Revenue, 2018-2029
6.5.2 By Country – Europe Bispecific Antibodies Drug Sales, 2018-2029
6.5.3 Germany Bispecific Antibodies Drug Market Size, 2018-2029
6.5.4 France Bispecific Antibodies Drug Market Size, 2018-2029
6.5.5 U.K. Bispecific Antibodies Drug Market Size, 2018-2029
6.5.6 Italy Bispecific Antibodies Drug Market Size, 2018-2029
6.5.7 Russia Bispecific Antibodies Drug Market Size, 2018-2029
6.5.8 Nordic Countries Bispecific Antibodies Drug Market Size, 2018-2029
6.5.9 Benelux Bispecific Antibodies Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Bispecific Antibodies Drug Revenue, 2018-2029
6.6.2 By Region – Asia Bispecific Antibodies Drug Sales, 2018-2029
6.6.3 China Bispecific Antibodies Drug Market Size, 2018-2029
6.6.4 Japan Bispecific Antibodies Drug Market Size, 2018-2029
6.6.5 South Korea Bispecific Antibodies Drug Market Size, 2018-2029
6.6.6 Southeast Asia Bispecific Antibodies Drug Market Size, 2018-2029
6.6.7 India Bispecific Antibodies Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Bispecific Antibodies Drug Revenue, 2018-2029
6.7.2 By Country – South America Bispecific Antibodies Drug Sales, 2018-2029
6.7.3 Brazil Bispecific Antibodies Drug Market Size, 2018-2029
6.7.4 Argentina Bispecific Antibodies Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Bispecific Antibodies Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Bispecific Antibodies Drug Sales, 2018-2029
6.8.3 Turkey Bispecific Antibodies Drug Market Size, 2018-2029
6.8.4 Israel Bispecific Antibodies Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Bispecific Antibodies Drug Market Size, 2018-2029
6.8.6 UAE Bispecific Antibodies Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Bispecific Antibodies Drug Major Product Offerings
7.1.4 Amgen Bispecific Antibodies Drug Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Immunocore
7.2.1 Immunocore Company Summary
7.2.2 Immunocore Business Overview
7.2.3 Immunocore Bispecific Antibodies Drug Major Product Offerings
7.2.4 Immunocore Bispecific Antibodies Drug Sales and Revenue in Global (2018-2023)
7.2.5 Immunocore Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Bispecific Antibodies Drug Major Product Offerings
7.3.4 Roche Bispecific Antibodies Drug Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
8 Global Bispecific Antibodies Drug Production Capacity, Analysis
8.1 Global Bispecific Antibodies Drug Production Capacity, 2018-2029
8.2 Bispecific Antibodies Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Bispecific Antibodies Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Bispecific Antibodies Drug Supply Chain Analysis
10.1 Bispecific Antibodies Drug Industry Value Chain
10.2 Bispecific Antibodies Drug Upstream Market
10.3 Bispecific Antibodies Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Bispecific Antibodies Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Bispecific Antibodies Drug in Global Market
Table 2. Top Bispecific Antibodies Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Bispecific Antibodies Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Bispecific Antibodies Drug Revenue Share by Companies, 2018-2023
Table 5. Global Bispecific Antibodies Drug Sales by Companies, (Units), 2018-2023
Table 6. Global Bispecific Antibodies Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Bispecific Antibodies Drug Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Bispecific Antibodies Drug Product Type
Table 9. List of Global Tier 1 Bispecific Antibodies Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bispecific Antibodies Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Bispecific Antibodies Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Bispecific Antibodies Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Bispecific Antibodies Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Bispecific Antibodies Drug Sales (Units), 2018-2023
Table 15. By Type - Global Bispecific Antibodies Drug Sales (Units), 2024-2029
Table 16. By Application – Global Bispecific Antibodies Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Bispecific Antibodies Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Bispecific Antibodies Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Bispecific Antibodies Drug Sales (Units), 2018-2023
Table 20. By Application - Global Bispecific Antibodies Drug Sales (Units), 2024-2029
Table 21. By Region – Global Bispecific Antibodies Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Bispecific Antibodies Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Bispecific Antibodies Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Bispecific Antibodies Drug Sales (Units), 2018-2023
Table 25. By Region - Global Bispecific Antibodies Drug Sales (Units), 2024-2029
Table 26. By Country - North America Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Bispecific Antibodies Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Bispecific Antibodies Drug Sales, (Units), 2018-2023
Table 29. By Country - North America Bispecific Antibodies Drug Sales, (Units), 2024-2029
Table 30. By Country - Europe Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Bispecific Antibodies Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Bispecific Antibodies Drug Sales, (Units), 2018-2023
Table 33. By Country - Europe Bispecific Antibodies Drug Sales, (Units), 2024-2029
Table 34. By Region - Asia Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Bispecific Antibodies Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Bispecific Antibodies Drug Sales, (Units), 2018-2023
Table 37. By Region - Asia Bispecific Antibodies Drug Sales, (Units), 2024-2029
Table 38. By Country - South America Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Bispecific Antibodies Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Bispecific Antibodies Drug Sales, (Units), 2018-2023
Table 41. By Country - South America Bispecific Antibodies Drug Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Bispecific Antibodies Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Bispecific Antibodies Drug Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Bispecific Antibodies Drug Sales, (Units), 2024-2029
Table 46. Amgen Company Summary
Table 47. Amgen Bispecific Antibodies Drug Product Offerings
Table 48. Amgen Bispecific Antibodies Drug Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Amgen Key News & Latest Developments
Table 50. Immunocore Company Summary
Table 51. Immunocore Bispecific Antibodies Drug Product Offerings
Table 52. Immunocore Bispecific Antibodies Drug Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Immunocore Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Bispecific Antibodies Drug Product Offerings
Table 56. Roche Bispecific Antibodies Drug Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Bispecific Antibodies Drug Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 59. Global Bispecific Antibodies Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Bispecific Antibodies Drug Production by Region, 2018-2023 (Units)
Table 61. Global Bispecific Antibodies Drug Production by Region, 2024-2029 (Units)
Table 62. Bispecific Antibodies Drug Market Opportunities & Trends in Global Market
Table 63. Bispecific Antibodies Drug Market Drivers in Global Market
Table 64. Bispecific Antibodies Drug Market Restraints in Global Market
Table 65. Bispecific Antibodies Drug Raw Materials
Table 66. Bispecific Antibodies Drug Raw Materials Suppliers in Global Market
Table 67. Typical Bispecific Antibodies Drug Downstream
Table 68. Bispecific Antibodies Drug Downstream Clients in Global Market
Table 69. Bispecific Antibodies Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Bispecific Antibodies Drug Segment by Type in 2022
Figure 2. Bispecific Antibodies Drug Segment by Application in 2022
Figure 3. Global Bispecific Antibodies Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Bispecific Antibodies Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Bispecific Antibodies Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Bispecific Antibodies Drug Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Bispecific Antibodies Drug Revenue in 2022
Figure 9. By Type - Global Bispecific Antibodies Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Bispecific Antibodies Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Bispecific Antibodies Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Bispecific Antibodies Drug Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Bispecific Antibodies Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Bispecific Antibodies Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Bispecific Antibodies Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Bispecific Antibodies Drug Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Bispecific Antibodies Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Bispecific Antibodies Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Bispecific Antibodies Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Bispecific Antibodies Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Bispecific Antibodies Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Bispecific Antibodies Drug Sales Market Share, 2018-2029
Figure 23. US Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Bispecific Antibodies Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Bispecific Antibodies Drug Sales Market Share, 2018-2029
Figure 28. Germany Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Bispecific Antibodies Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Bispecific Antibodies Drug Sales Market Share, 2018-2029
Figure 37. China Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Bispecific Antibodies Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Bispecific Antibodies Drug Sales Market Share, 2018-2029
Figure 44. Brazil Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Bispecific Antibodies Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Bispecific Antibodies Drug Sales Market Share, 2018-2029
Figure 48. Turkey Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Bispecific Antibodies Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Bispecific Antibodies Drug Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Bispecific Antibodies Drug by Region, 2022 VS 2029
Figure 54. Bispecific Antibodies Drug Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 二重特異性抗体医薬品の世界市場見通し2023年-2029年(Bispecific Antibodies Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 細胞結合型二重特異性抗体の世界市場見通し2023年-2029年
  • 二重特異性抗体の世界市場2023年～2030年：疾患別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆